Radiopharm Theranostics (RADX) director Ian Turner reports share and option holdings
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
Radiopharm Theranostics Ltd director Ian Lawrence Turner has filed an initial Form 3 detailing his equity position in RADX. The filing shows direct ownership of 6,985,292 Ordinary Shares and indirect ownership of 3,000,000 Ordinary Shares held through the Turner Discretionary Trust, where he is the sole beneficiary.
Mr. Turner also holds multiple option awards over Ordinary Shares with exercise prices ranging from 0.0250 to 0.2000 per share and expirations between 2026 and 2030. Footnotes explain that several grants vest in tranches between July 2026 and July 2028, in some cases only if he remains a director or achieves specified milestones.
Positive
- None.
Negative
- None.
Insider Trade Summary
16 transactions reported
Mixed
16 txns
Insider
Turner Ian Lawrence
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Option (right to buy) | -- | -- | -- |
| holding | Option (right to buy) | -- | -- | -- |
| holding | Option (right to buy) | -- | -- | -- |
| holding | Option (right to buy) | -- | -- | -- |
| holding | Option (right to buy) | -- | -- | -- |
| holding | Option (right to buy) | -- | -- | -- |
| holding | Option (right to buy) | -- | -- | -- |
| holding | Option (right to buy) | -- | -- | -- |
| holding | Option (right to buy) | -- | -- | -- |
| holding | Option (right to buy) | -- | -- | -- |
| holding | Option (right to buy) | -- | -- | -- |
| holding | Option (right to buy) | -- | -- | -- |
| holding | Option (right to buy) | -- | -- | -- |
| holding | Option (right to buy) | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
Holdings After Transaction:
Option (right to buy) — 6,814,000 shares (Direct);
Option (right to buy) — 750,000 shares (Indirect, Held through Mr. Turner's superannuation fund);
Ordinary Shares — 6,985,292 shares (Direct);
Ordinary Shares — 3,000,000 shares (Indirect, Held through the Turner Discretionary Trust, of which Mr. Turner is the sole beneficiary)
Footnotes (1)
- Granted on December 12, 2025. 2,271,333 options will vest on July 1, 2026, 2,271,333 options will vest on July 1, 2027 and 2,271,334 options will vest on July 1, 2028 provided Mr. Turner is still a Director on such dates. Granted on December 16, 2024. 2,666,667 options will vest on September 30, 2026 and 2,666,666 options will vest on September 30, 2027 provided Mr. Turner is still a Director on such dates. Granted on December 16, 2024. 1,346,801 options will vest on July 1, 2026 and 1,346,802 options will vest on July 1, 2027 subject to Mr. Turner achieving certain milestones. Granted on December 1, 2023. 483,768 options will vest on July 1, 2026 subject to Mr. Turner achieving certain milestones.
Key Figures
Direct Ordinary Share Holdings: 6,985,292 shares
Indirect Ordinary Share Holdings: 3,000,000 shares
Largest Option Grant: 6,814,000 underlying shares at 0.0250 per share
+5 more
8 metrics
Direct Ordinary Share Holdings
6,985,292 shares
Total Ordinary Shares held directly as of 2026-03-18
Indirect Ordinary Share Holdings
3,000,000 shares
Ordinary Shares held through the Turner Discretionary Trust
Largest Option Grant
6,814,000 underlying shares at 0.0250 per share
Option over Ordinary Shares expiring 2030-07-01, direct
2024 Option Grant (0.0600)
2,666,667 underlying shares at 0.0600 per share
Option expiring 2029-09-30, direct holding
Milestone-based Option Grant
1,346,801 underlying shares at 0.0410 per share
Granted 2024-12-16; vesting from 2026 subject to milestones
Superannuation Fund Options
750,000 underlying shares at 0.0600 per share
Indirect holding via Mr. Turner’s superannuation fund, expires 2026-08-24
Higher-price Options
550,448 underlying shares at 0.1700 per share
Option expiring 2027-07-30, direct holding
Earliest Grant Exercise Price
0.2000 per share
Option over 70,422 underlying shares, expiring 2026-11-30
Key Terms
Option (right to buy), Ordinary Shares, superannuation fund, Turner Discretionary Trust, +2 more
6 terms
Option (right to buy) financial
"security_title": "Option (right to buy)""
superannuation fund financial
"Held through Mr. Turner's superannuation fund"
Turner Discretionary Trust financial
"Held through the Turner Discretionary Trust, of which Mr. Turner is the sole beneficiary"
milestones financial
"options will vest on July 1, 2026 subject to Mr. Turner achieving certain milestones"
Milestones are specific, measurable progress points a company aims to reach during a project—like completing a clinical trial step, securing a regulatory approval, or hitting a sales target. They matter to investors because each checkpoint reduces uncertainty about the business plan, can trigger payments or changes in valuation, and often signals whether future revenue or growth is likely, similar to passing checkpoints on a racecourse that show how close you are to the finish line.
vesting financial
"options will vest on July 1, 2026, 2027 and 2028 provided Mr. Turner is still a Director"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
